图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:ALCOHOL

ISSN:0741-8329
版本:SCI-CDE
出版频率:Bi-monthly
出版社:ELSEVIER SCIENCE INC, STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169
  出版社网址:http://www.elsevier.com/
期刊网址:http://www.elsevier.com/wps/find/journaldescription.cws_home/525453/description#description
影响因子:2.405
主题范畴:SUBSTANCE ABUSE;    PHARMACOLOGY & PHARMACY;    TOXICOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

Alcohol is an international, peer-reviewed journal that is devoted to publishing multi-disciplinary biomedical research on all aspects of the actions or effects of alcohol on the nervous system or on other organ systems. Emphasis is given to studies into the causes and consequences of alcohol abuse and alcoholism, and biomedical aspects of diagnosis, etiology, treatment or prevention of alcohol-related health effects. Intended for both research scientists and practicing clinicians, the journal publishes original research on the neurobiological, neurobehavioral, and pathophysiological processes associated with alcohol drinking, alcohol abuse, alcohol-seeking behavior, tolerance, dependence, withdrawal, protracted abstinence, and relapse. In addition, the journal reports studies on the effects alcohol on brain mechanisms of neuroplasticity over the life span, biological factors associated with adolescent alcohol abuse, pharmacotherapeutic strategies in the treatment of alcoholism, biological and biochemical markers of alcohol abuse and alcoholism, pathological effects of uncontrolled drinking, biomedical and molecular factors in the effects on liver, immune system, and other organ systems, and biomedical aspects of fetal alcohol spectrum disorder including mechanisms of damage, diagnosis and early detection, treatment, and prevention. Articles are published from all levels of biomedical inquiry, including the following: molecular and cellular studies of alcohol's actions in vitro and in vivo; animal model studies of genetic, pharmacological, behavioral, developmental or pathophysiological aspects of alcohol; human studies of genetic, behavioral, cognitive, neuroimaging, or pathological aspects of alcohol drinking; clinical studies of diagnosis (including dual diagnosis), treatment, prevention, and epidemiology. The journal will publish 9 issues per year; the accepted abbreviation for Alcohol for bibliographic citation is Alcohol.

Alcohol subscribes to the tenets of The Farmington Consensus (see
http://www.elsevier.com/framework_products/promis_misc/525453fc.pdf or http://www1.elsevier.com/homepage/sab/alcohol/fconsensus.htm ). Submission of a paper to the journal will be taken as evidence that the authors have complied with the tenets set forth in the Consensus. All submitted material will be subject to peer review. Alcohol considers three types of manuscripts for publication:

- Original research articles are full-length reports of the authors' original research addressing topics consistent with the Aims and Scope of the journal. Submissions outside the scope of the journal, or incomplete or fragmentary submissions, will not be considered.

- Rapid communications are original, high-quality manuscripts that describe new data of high impact and major importance to the field. These contributions are typically short (e.g., 4 journal pages), and will be peer-reviewed by at least one expert in the field of the research and an Editor, and will be either accepted with minimal or no revisions or rejected. Publication of accepted rapid communications will be expedited.

- Invited review articles will be considered for publication, upon invitation from the Editor-in-Chief, as full-length papers or mini-reviews. These contributions will be peer-reviewed. Contact the Editor-in-Chief concerning the suitability of a topic for an invited review.

There are no page charges for articles published in Alcohol, and the current practice is to provide the corresponding author with 50 free reprints of his/her article. Effective May 2006, authors from all countries are invited to submit manuscripts, complete in all respects and following the Instructions to Authors (revised May 2006), to Charles R. Goodlett, Editor-in-Chief, via Elsevier electronic submission at
http://ees.elsevier.com/alcohol

Contact for questions:
Charles R. Goodlett
Editor-in-Chief, Alcohol
Department of Psychology
IUPUI
402 North Blackford Street
Indianapolis, IN 46202-3275

Tel: +1-317 274-6772
Fax: +1-317 278-7181
E-mail:
alcojrnl@iupui.edu


Editor-in-Chief:
Charles R. Goodlett PhD


Instructions to Authors

MANUSCRIPT SUBMISSION

Authors are encouraged to review the Aims and Scope to determine whether their contribution is suitable for publication in Alcohol. All submitted material will be subject to peer review. The requirements set forth in the Instructions to Authors apply to all 3 types of manuscripts accepted for publication in Alcohol, as follows:

- Original research articles are full-length reports of the authors' original research addressing topics consistent with the Aims and Scope of the journal. Submissions outside the scope of the journal, or incomplete or fragmentary submissions, will not be considered.

- Rapid communications are original, high-quality manuscripts that describe new data of high impact and major importance to the field. These contributions are typically short (e.g., 4 journal pages), and will be peer-reviewed by at least one expert in the field of the research and an Editor, and will be either accepted with minimal or no revisions or rejected. Publication of accepted rapid communications will be expedited.

- Invited review articles will be considered for publication, upon invitation from the Editor-in-Chief or Associate Editor, as full-length reviews or mini-reviews. These contributions will be peer-reviewed. Authors should contact the Editor-in-Chief concerning the suitability of a topic for an invited review.

- Invited editorials or commentaries will be considered for publication, upon agreement by the Editor-in-Chief and Associate Editor. These contributions should be relatively short (2-3 journal pages), and focused on topics of high current interest, controversy, or fast-paced change. They will be peer reviewed by at least one member of the Editorial staff and another recognized expert in the area. Authors should contact the Editor-in-Chief concerning the suitability of a topic for an invited editorial or commentary.

Authors from all countries are invited to submit manuscripts (complete in all respects) to the Editor-in-Chief using Elsevier's web-based electronic submission at the following URL:
http://ees.elsevier.com/alcohol/ (instructions are provided below).

Alcohol subscribes to the tenets of
The Farmington Consensus (pdf). Submission of a paper to the journal will be taken as evidence that the authors have complied with the tenets set forth in the Consensus, including the "Expectations of Authors". Consistent with those tenets, requirements for authorship are: (1) substantial contribution to conception, design, acquisition, analysis, and/or interpretation of data; (2) contribution to the writing and intellectual content of the article; and (3) final approval of the submitted manuscript.

Electronic Submission

All manuscripts are to be submitted and reviewed electronically using the journal's EES web site (
http://ees.elsevier.com/alcohol/). Prepare your manuscript in one of the following formats: MS Word, WordPerfect 6.1 (or higher) or LaTeX. Acceptable figure formats are TIFF, EPS, PDF or MS Office files (Word, Powerpoint, Excel), but TIFF or EPS formats are preferred.

Authors should prepare the following items, using standard word processing and graphics/imaging tools, in preparation for electronic submission of their manuscript:

1. Electronic copy of the Cover Letter (as a document file), signed by corresponding author, briefly describing the work and explicitly stating and signing for the following assurances:
(a) that all co-authors have read, approve of, and concur with the submitted manuscript;
(b) that all authors have made substantial contributions that meet the stated requirements for authorship;
(c) that due care has been exercised by the authors to ensure the integrity of the work;
(d) that none of the original material contained in the manuscript has been previously published (except in abstract form as part of scientific meetings) nor is currently under review for publication elsewhere;
(e) that any commercial affiliation or consultant role of an author that could be construed as a conflict of interest has been acknowledged (or a statement indicating that no such conflict of interest exists);
(f) any necessary accompanying documentation (e.g., signed permission letter to include previously published material in the contribution) is included;
(g) a list of up to 3 suggested reviewers (with complete mailing address and e-mail address) who could potentially review the contribution. (Note, however, that the final choice of reviewers will be the prerogative and responsibility of the Editors.)

2. Electronic copy of the Manuscript (as a document file), that includes Title & Author page, Abstract, Key Word list, Manuscript text, references; tables may be included in the manuscript or may be prepared and uploaded as separate files. 3. Electronic copies of each figure (as a separate file), preferably in either TIFF (Tagged Image File Format) or EPS (Encapsulated Post Script) format; acceptable alternative figure formats are PDF or MS Office files (Word, Powerpoint, Excel) Each figure is to be uploaded as a separate file.

MANUSCRIPT FORMAT AND STYLE

Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review. For manuscripts under revision, contributions not revised and returned to the editorial office within 3 months after being returned to the authors for revision may be considered as withdrawn, unless the communicating author requests an extension.

Title Page: Include (a) complete title of manuscript; (b) authors' full names, (c) name of affiliation, laboratory or institution of each author including city, state or province, ZIP or postal code, and country (footnoted and listed on separate lines if more than one laboratory or institution); (c) name and complete address for correspondence, including the corresponding author's telephone and fax numbers and e-mail address.

Abstract and Keywords: Include an abstract that briefly summarizes the work, limited to a short paragraph of about 300 words. Succinctly state purpose of the study, basic methods and procedures, the most important findings, and principal conclusions. Prepare as one continuous paragraph without sections or subheadings. At the bottom of the abstract, provide a list of up to 6 key words or short phrases, in italics, suitable for indexing terms.

Text Organization: Include the following main sections in with section headings (Introduction, Materials and Methods, Results, and Discussion) on separate lines and in bold font. (Note: As of April 2007, the format will no longer use numbering of main sections or sub-sections in the manuscript).

Introduction
In this section, the objectives of the research should be clearly stated. Relevant background information and published studies should be described concisely, and be cited appropriately.

Materials and Methods
This section should contain all the details necessary to reproduce the experiments. Avoid re-describing complete details of methods already published. [Include subsections, labeled in italics, if applicable and as needed (e.g., Subjects, Apparatus, Drug Treatments, Procedures, Statistical Analyses)]. If experimental animals were used, include a statement indicating whether the research was reviewed in advance by the institutional Animal Care and Use Committee and whether the research was conducted according to the requirements of all applicable local, national, and international standards for the care and use of laboratory animals (indicating the specific guidelines followed, e.g., the NIH Guide for the Care and Use of Laboratory Animals). If human subjects were involved, include a statement indicating both (a) that written informed consent was obtained from each human subject and (b) that the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983.

Results
The results should be described clearly and concisely, and in logical order without extended discussion of their significance. Results should usually be presented descriptively, supported with appropriate statistical analyses, and be supplemented by photographs or diagrams.

Discussion
The results of the research should be discussed in the context of other relevant published work, and as concisely as possible. Extensive citations and discussion of published literature should be avoided.

References (see below)

Tables (each on separate page; see below)
Figure legends (presented as a group; see below)
Figures (each uploaded as a separate figure; be sure to identify the figure number correctly when it is uploaded; see below)

Abbreviations
Use in abstract only if necessary. Terms appearing frequently within the text of the manuscript may be abbreviated (do not abbreviate the term "ethanol"). For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814). Write out the full term for each abbreviation at its first use (unless it is a standard unit of measure), with the abbreviation following in parentheses; terms should not be abbreviated in tables or figures. Abbreviations that appear as word entries in Merriam-Webster's Collegiate Dictionary do not need to be defined the first time they are used. Abbreviations are to be used for standard Latin terms, statistics, and reference terms in parenthetical material (e.g., i.e.,), as well as for standard units of measure.

Formulas and Equations
Include structural chemical formulas, process flow diagrams, and complicated mathematical expressions sparingly. Create (usually) chemical formulas and flow diagrams for reproduction as line cuts. Ensure all subscript, superscript, Greek, and unusual characters are clearly identified.

Drugs
Provide the chemical name to precede the trade name (or popularly known name) for all drugs. Capitalize proprietary names (trade names).

Acknowledgments
Declare all sources of funding for the contribution in an acknowledgement section to precede the reference list. If there were no sources of funding, please state this in the cover letter.

References
Effective April 2007, the style for citations and references to be used is that used by Cell Press journals. This referencing style is available on electronic citation management software, e.g., EndNote, for Cell Press journals (e.g., Cell; Neuron).

References should include only articles that are published or in press. In-text citations should include all author surnames for materials written by one or by two authors, e.g., (Miller, 1995; Smith and Jones, 1973); for material written by three or more authors, use first author surname and et al., e.g., (Homanics et al., 2006). Unpublished data, submitted manuscripts, or personal communications should be cited parenthetically within the text only, e.g., (unpublished observation, D. J. Tuma, 1999), and not listed in the references. Citation of personal communications or other unpublished work of others must be documented by a letter of permission. Abstracts of work presented at meetings may not be cited.

References should be arranged alphabetically by author surname(s). References by the same author(s) should be arranged chronologically. All authors (up to 10) should be listed in the reference; "et al." should only be used after the first 10 authors. The following are examples of common types of citations:

Article in a periodical: Roberto, M., Madamba, S.G., Moore, S.D., Tallent, M.K., and Siggins, G.R. (2003). Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc. Natl. Acad. Sci. USA 100, 2053-2058.

Article in a book: Jerrells, T.R., and Pruett, S.B. (1994). Immunotoxic effects of ethanol. In Immunotoxicology and Immunopharmacology, J.H. Dean, M.I. Luster, A.E. Munson, and I. Kimber, eds. (New York: Raven Press), pp. 323-347.

An edited book: Liu, Y., and Hunt, W.A., eds (1999). The 'Drunken' Synapse: Studies of Alcohol Related Disorders (New York: Klewer Academic/Plenum Publishers).

An authored book: Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd edn (Hillsdale, NJ: Lawrence Erlbaum Associates).

Figure Captions
Include captions for all figures. They should be brief and specific, and should appear on a separate manuscript page after the references. Identify the scale markers used in the image for photomicrographs, and indicate the type of stain used for histological figures.

Figures: Please observe the following instructions:

" The figures should be submitted on EES preferably in either TIFF (Tagged Image File Format) or EPS (Encapsulated Post Script) format, at the standard resolutions (i.e., 300 dpi for photos, 1200 dpi for line art) and sized at the final print size in the journal. When possible, prepare the figure sized for use in a single column width of journal space.

For drawings that will be reduced to a given size, draw and letter the figure to the same scale to ensure that all lettering remains legible once the figure is reduced

Refer to all illustrations as figures, and number figures with Arabic numerals.

Place all lettering within the framework of the figure and ensure that the key to symbols is displayed in the face of the chart (rather than described in the legend). Use standard symbols that are easily available for typesetting, e.g., circles, squares, and triangles. Designate group differences with asterisks.

Provide dimension scale bar for all photomicrographs.

If color reproduction is requested, submit color prints in actual size; note that authors are responsible for the additional costs to process and print color figures.


Tables
Create tables using the "Table" feature of your word processing software. Do not use Excel or comparable spreadsheet programs to create tables. Cite tables consecutively in the text, and number them in that order. Each table should appear as a separate file (if uploaded separately) or on a separate sheet (if included as part of the uploaded manuscript). Each table should include the table title, appropriate column heads, and explanatory footnotes (including definitions of any abbreviations used). Use superscript, lowercase letters in descending alphabetic order as footnote symbols. Identify statistical measures of variation, standard deviation (S.D.), standard error of the mean (S.E.M.), and so forth in footnotes, but designate statistical significance in the table body and footnotes with asterisks (*, **, ***). Do not embed tables within the body of the manuscript; place them either at the end of the manuscript or upload them as separate files. Tables should be able to stand alone and be self-explanatory (i.e., no aspect requires the reader to refer to the text or other material outside the table for explanation), and they should supplement, rather than duplicate, the material in the text or figures.

POLICIES

Animal Experimentation
When experimental animals are used, the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23) revised 1996, the European Communities Council Directive of 24 November 1986 (86/609/EEC), or the UK Animals (Scientific Procedures) Act 1986.

Human Subjects
It is the authors' responsibility to verify and state explicitly that any experimental investigation with human subjects reported in the manuscript was performed following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated (e.g., prior approval by the Institutional Review Board, meeting requirements for informed consent and for confidentiality and full protection of the subjects' anonymity). All procedures should follow the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983.

Permissions
Obtain written permission from both the original author and the publisher for any previously published figures, tables, or materials to be included as part of the manuscript. Submit evidence of this written permission with the original contribution. [Permissions Form:
http://www.elsevier.com/framework_products/promis_misc/525453pf_1.htm ]

MANUSCRIPT PUBLICATION

Copyright Transfer: Publications are copyrighted for the protection of the authors and the publisher. A transfer of copyright agreement will be sent to the corresponding author from the publisher (language is included in this agreement which waives the copyright transfer for US Federal employees). The completed and signed copyright transfer form must be returned to the publisher before articles can be published.

Author Proofs: Responsibility for proofreading remains with the author. One set of proofs will be sent to the corresponding author. A form with queries from the copyeditor may accompany your proofs. Please answer all queries and make any corrections within 2 days of receipt. No alteration of the substance of the text, tables or figures will be allowed at this stage; restrict corrections to author proofs to printer's errors only. Costs for any other alterations will be charged to the author. Should there be no corrections, please confirm this. Elsevier will do everything possible to get your article corrected and published as quickly and accurate as possible. In order to do this we need your help. When you receive the (PDF) proof of your article for correction it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.

Electronic (PDF) personal copies and hard-copy reprints: The corresponding author of an article published in the journal will receive an electronic (PDF) copy of his or her article with permission granted for personal use, free of charge. Additional hard-copy reprints may be ordered by using the reprint order form received by the corresponding author with his or her author proofs. To order hard-copy reprints, the authors should complete this order form and return it with the proofs.

Tracking Accepted Manuscripts: After acceptance of your article by the journal, and following receipt of the files at Elsevier, authors can keep track of the progress of their accepted article, and set up e-mail alerts informing them of changes in their manuscript's status using the 'Track Your Paper' feature of Elsevier's
Author Gateway. You will receive a unique reference code together with the acknowledgement e-mail from Elsevier sent upon receipt of your manuscript files in the Elsevier production system.


Editorial Board

Editor-in-Chief:

T.R. Jerrells, University of Nebraska Medical Center, Department of Pathology and Microbiology, 986495 Nebraska Medical Center, Omaha, NE 68198-6495, USA

Associate Editor for Europe:

S. Borg, Beroendecentrum Stockholm, Box 125 60, 102 29 Stockholm, Sweden

Managing Editor:

J.M. Jerrells, Three Forks Editorial Consultants, 11912 Gow Lane, Bellevue, NE 68123-1116, USA

Editorial Board:

G. Colombo, Cagliari, Italy
R.T. Cook, Iowa City, IA, USA
J.C. Crabbe, Portland, OR, USA
Ph. de Witte, Louvain-la-Neuve, Belgium
C.J.P. Eriksson, Helsinki, Finland
G.L. Gessa, Cagliari, Italy
R.A. Gonzales, Austin, TX, USA
C.R. Goodlett, Indianapolis, IN, USA
S. Govoni, Pavia, Italy
L.A. Grupp, Toronto, Ontario, Canada
C. Guerri, Valencia, Spain
R.A. Harris, Austin, TX, USA
F.A. Holloway, Oklahoma City, OK, USA
Y. Israel, Philadelphia, PA, USA, and Santiago, Chile
H. Kalant, Toronto, Ontario, Canada
S.W. Kiefer, Manhattan, KS, USA
K. Kiianmaa, Helsinki, Finland
G. Koob, La Jolla, CA, USA
E.R. Korpi, Turku, Finland
W. Kostowski, Warsaw, Poland
E.J. Kovacs, Maywood, IL, USA
W.J. McBride, Indianapolis, IN, USA
E. Mezey, Baltimore, MD, USA
J. Morland, Oslo, Norway
E.P. Noble, Los Angeles, CA, USA
T.J. Peters, London, UK
L.A. Pohorecky, Piscataway, NJ, USA
S.B. Pruett, Shreveport, LA, USA
H. Rommelspacher, Berlin, Germany
R.M. Salimov, Moscow, Russia
H.H. Samson, Winston-Salem, NC, USA
J.D. Sinclair, Helsinki, Finland
D.J. Tuma, Omaha, NE, USA
S. Worrall, Brisbane, Queensland, Australia
J.L. York, Buffalo, NY, USA

Founding Editor:

R.D. Myers



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有